LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677 | -4.1% | 11,300 | +15.3% | 0.00% | 0.0% |
| Q2 2023 | $706 | -67.3% | 9,800 | -66.7% | 0.00% | 0.0% |
| Q1 2023 | $2,160 | +194.3% | 29,400 | +167.3% | 0.00% | 0.0% |
| Q4 2022 | $734 | -99.9% | 11,000 | +46.7% | 0.00% | 0.0% |
| Q3 2022 | $645,000 | -3.6% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $669,000 | -16.2% | 7,500 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $798,000 | -27.2% | 7,100 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $1,096,000 | +10.8% | 7,100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $989,000 | -14.3% | 7,100 | -19.3% | 0.00% | 0.0% |
| Q2 2021 | $1,154,000 | +152.5% | 8,800 | +193.3% | 0.00% | +100.0% |
| Q1 2021 | $457,000 | +1244.1% | 3,000 | +900.0% | 0.00% | – |
| Q2 2019 | $34,000 | -83.1% | 300 | -81.2% | 0.00% | -100.0% |
| Q1 2019 | $201,000 | -97.1% | 1,600 | -96.8% | 0.00% | -97.1% |
| Q4 2018 | $6,825,000 | +654.1% | 50,300 | +1424.2% | 0.04% | +775.0% |
| Q3 2018 | $905,000 | +68.2% | 3,300 | +26.9% | 0.00% | +100.0% |
| Q2 2018 | $538,000 | +42.0% | 2,600 | +13.0% | 0.00% | 0.0% |
| Q1 2018 | $379,000 | +63.4% | 2,300 | +35.3% | 0.00% | +100.0% |
| Q4 2017 | $232,000 | -91.8% | 1,700 | -91.9% | 0.00% | -91.7% |
| Q3 2017 | $2,845,000 | +1712.1% | 20,900 | +1507.7% | 0.01% | +1100.0% |
| Q2 2017 | $157,000 | +273.8% | 1,300 | +225.0% | 0.00% | – |
| Q1 2017 | $42,000 | +5.0% | 400 | 0.0% | 0.00% | – |
| Q4 2016 | $40,000 | -56.0% | 400 | -55.6% | 0.00% | – |
| Q3 2016 | $91,000 | -52.1% | 900 | -43.8% | 0.00% | -100.0% |
| Q2 2016 | $190,000 | +48.4% | 1,600 | +33.3% | 0.00% | 0.0% |
| Q1 2016 | $128,000 | -78.1% | 1,200 | -77.8% | 0.00% | -66.7% |
| Q4 2015 | $585,000 | -41.6% | 5,400 | -53.8% | 0.00% | -40.0% |
| Q3 2015 | $1,002,000 | – | 11,700 | – | 0.01% | – |
| Q1 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2014 | $926,000 | -47.9% | 17,400 | -54.0% | 0.00% | 0.0% |
| Q3 2014 | $1,776,000 | +71.8% | 37,800 | +127.7% | 0.00% | -20.0% |
| Q2 2014 | $1,034,000 | +2.5% | 16,600 | +10.7% | 0.01% | 0.0% |
| Q1 2014 | $1,009,000 | +2.5% | 15,000 | -19.8% | 0.01% | +25.0% |
| Q4 2013 | $984,000 | +36.1% | 18,700 | +12.0% | 0.00% | +33.3% |
| Q3 2013 | $723,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |